Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
Open accessPublished version of a preprint
Abstract
Prime editors (PEs) mediate genome modification without utilizing double-stranded DNA breaks or exogenous donor DNA as a template. PEs facilitate nucleotide substitutions or local insertions or deletions within the genome based on the template sequence encoded within the prime editing guide RNA (pegRNA). However, the efficacy of prime editing in adult mice has not been established. Here we report an NLS-optimized SpCas9-based prime editor that improves genome editing efficiency in both fluorescent reporter cells and at endogenous loci in cultured cell lines. Using this genome modification system, we could also seed tumor formation through somatic cell editing in the adult mouse. Finally, we successfully utilize dual adeno-associated virus (AAVs) for the delivery of a split-intein prime editor and demonstrate that this system enables the correction of a pathogenic mutation in the mouse liver. Our findings further establish the broad potential of this genome editing technology for the directed installation of sequence modifications in vivo, with important implications for disease modeling and correction.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
For insertions or deletions of 10 base pairs or more, the RT should be extended by at least 25 nucleotides.
“If the goal is to insert or delete larger portions of DNA (from 10 base pairs onwards) include an extended RT of at least 25 nucleotides47”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [47]
The Results (Fig. 1 and Fig. 2; page unavailable) report targeted deletions of 47 and 32 bp and an 18-bp insertion, supporting the use of prime editing for changes of at least 10 bp. The paper does not state that these edits require, or should use, an RT template of at least 25 nucleotides. (LLM, conf=0.78)
Experimental — accuracy not yet measuredExtending the RT part of the pegRNA 10 nucleotides beyond the edit of interest is optimal for most point mutations and indels.
“Extend the RT-part of the pegRNA 10 nucleotides beyond your edit of interest. As this has been found to be optimal for most point mutations and indels.”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [47]
The Introduction explains that a pegRNA encodes an RT template, and the Results compare prime-editor performance for point mutations, deletions, and insertions. Neither passage evaluates RT-template extension length or says that extending it 10 nucleotides beyond the edit is optimal. Searches for that length and for RT-template optimization found no supporting passage in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · see citing works
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184 · see citing works
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687 · see citing works
Varghese, F., Bukhari, A. B., Malhotra, R., & De, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096801 · Cited by 1,318 · see citing works
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Walton, R. T., Christie, K. A., Whittaker, M. N., & Kleinstiver, B. P. (2020) · Science · doi:10.1126/science.aba8853 · Cited by 1,233 · see citing works
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876 · see citing works
Self-citationPrime genome editing in rice and wheat
Lin, Q., Zong, Y., Xue, C., Wang, S., Jin, S., Zhu, Z., Wang, Y., Anzalone, A. V., Raguram, A., Doman, J. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0455-x · Cited by 873 · see citing works
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Maddalo, D., Manchado, E., Concepcion, C. P., Bonetti, C., Vidigal, J. A., Han, Y.-C., Ogrodowski, P., Crippa, A., Rekhtman, N., de Stanchina, E., et al. (2014) · Nature · doi:10.1038/nature13902 · Cited by 640 · see citing works
A New Class of Medicines through DNA Editing
Porteus, M. H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1800729 · Cited by 229 · see citing works
Flagged first, then by citations
Research works printed but not linked: 41
- [2]Panier S Boulton SJ Double-strand break repair: 53BP1 comes into focus Nat. Rev. Mol. Cell Biol. 2014 15 7 18 10.1038/nrm3719 24326623 · DOI
- [3]Suzuki K In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration Nature 2016 540 144 149 10.1038/nature20565 27851729 PMC5331785 · DOI · Paper page
- [4]Pickar-Oliver A Gersbach CA The next generation of CRISPR-Cas technologies and applications Nat. Rev. Mol. Cell Biol. 2019 20 490 507 10.1038/s41580-019-0131-5 31147612 PMC7079207 · DOI · Paper page
- [5]Rees HA Liu DR Base editing: precision chemistry on the genome and transcriptome of living cells Nat. Rev. Genet. 2018 19 770 788 10.1038/s41576-018-0059-1 30323312 PMC6535181 · DOI · Paper page
- [6]Anzalone AV Search-and-replace genome editing without double-strand breaks or donor DNA Nature 2019 576 149 157 10.1038/s41586-019-1711-4 31634902 PMC6907074 · DOI · Paper page
- [8]Schene IF Prime editing for functional repair in patient-derived disease models Nat. Commun. 2020 11 5352 10.1038/s41467-020-19136-7 33097693 PMC7584657 · DOI
- [9]Geurts, M. H. et al. Evaluating CRISPR-based Prime Editing for cancer modeling and CFTR repair in intestinal organoids. bioRxiv 2020.2010.2005.325837 (2020). PMC8356249 34373320
- [10]Liu Y Efficient generation of mouse models with the prime editing system Cell Discov. 2020 6 27 10.1038/s41421-020-0165-z 32351707 PMC7186222 · DOI
- [11]Aida, T. et al. Prime editing primarily induces undesired outcomes in mice. bioRxiv 2020.2008.2006.239723 (2020).
- [12]Wu Y Highly efficient therapeutic gene editing of human hematopoietic stem cells Nat. Med. 2019 25 776 783 10.1038/s41591-019-0401-y 30911135 PMC6512986 · DOI · Paper page
- [13]Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol.36, 843–846 (2018). PMC6126947 29813047
- [14]Zafra, M. P. et al. Optimized base editors enable efficient editing in cells, organoids and mice. Nat. Biotechnol.36, 888–893 (2018). PMC6130889 29969439
- [15]Song C-Q Adenine base editing in an adult mouse model of tyrosinaemia Nat. Biomed. Eng. 2020 4 125 130 10.1038/s41551-019-0357-8 31740768 PMC6986236 · DOI · Paper page
- [17]Ray M Tang R Jiang Z Rotello VM Quantitative tracking of protein trafficking to the nucleus using cytosolic protein delivery by nanoparticle-stabilized nanocapsules Bioconjugate Chem. 2015 26 1004 1007 10.1021/acs.bioconjchem.5b00141 PMC4743495 26011555 · DOI
- [18]Makkerh JP Dingwall C Laskey RA Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids Curr. Biol. 1996 6 1025 1027 10.1016/S0960-9822(02)00648-6 8805337 · DOI
- [20]Kleinstiver BP Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition Nat. Biotechnol. 2015 33 1293 1298 10.1038/nbt.3404 26524662 PMC4689141 · DOI · Paper page
- [21]Certo MT Tracking genome engineering outcome at individual DNA breakpoints Nat. Methods 2011 8 671 676 10.1038/nmeth.1648 21743461 PMC3415300 · DOI
- [22]Mir A Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing Nat. Commun. 2018 9 2641 10.1038/s41467-018-05073-z 29980686 PMC6035171 · DOI
- [23]Iyer, S. et al. Efficient homology-directed repair with circular ssDNA donors. bioRxiv 864199 (2019). PMC9595650 36070530
- [24]Dean M Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study Science 1996 273 1856 1862 10.1126/science.273.5283.1856 8791590 · DOI
- [25]Liu R Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 1996 86 367 377 10.1016/S0092-8674(00)80110-5 8756719 · DOI · Paper page
- [26]Samson M Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 1996 382 722 725 10.1038/382722a0 8751444 · DOI
- [27]Bolukbasi MF Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing Nat. Commun. 2018 9 4856 10.1038/s41467-018-07310-x 30451839 PMC6242970 · DOI
- [28]Loring HS Flotte TR Current status of gene therapy for alpha-1 antitrypsin deficiency Expert Opin. Biol. Ther. 2015 15 329 336 10.1517/14712598.2015.978854 25363251 · DOI
- [29]Carlson JA Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice J. Clin. Invest. 1989 83 1183 1190 10.1172/JCI113999 2784798 PMC303805 · DOI
- [31]Liu F Song Y Liu D Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther. 1999 6 1258 1266 10.1038/sj.gt.3300947 10455434 · DOI
- [32]Zucman-Rossi J Villanueva A Nault JC Llovet JM Genetic landscape and biomarkers of hepatocellular carcinoma Gastroenterology 2015 149 1226 1239 10.1053/j.gastro.2015.05.061 26099527 · DOI · Paper page
- [33]Liu P A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis Hepatology 2017 66 167 181 10.1002/hep.29183 28370287 PMC5481473 · DOI
- [34]Marquardt JU Andersen JB Thorgeirsson SS Functional and genetic deconstruction of the cellular origin in liver cancer Nat. Rev. Cancer 2015 15 653 667 10.1038/nrc4017 26493646 · DOI
- [35]Wang, D. A.-O., Tai, P. A.-O. & Gao, G. A.-O. Adeno-associated virus vector as a platform for gene therapy delivery. 18, 358–378 (2019). PMC6927556 30710128
- [36]Levy JM Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses Nat. Biomed. Eng. 2020 4 97 110 10.1038/s41551-019-0501-5 31937940 PMC6980783 · DOI
- [37]Zettler J Schütz V Mootz HD The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction FEBS Lett. 2009 583 909 914 10.1016/j.febslet.2009.02.003 19302791 · DOI
- [38]Wright AV Rational design of a split-Cas9 enzyme complex Proc. Natl Acad. Sci. USA 2015 112 2984 2989 10.1073/pnas.1501698112 25713377 PMC4364227 · DOI
- [39]Giannoukos G UDiTaS™, a genome editing detection method for indels and genome rearrangements BMC Genomics 2018 19 212 10.1186/s12864-018-4561-9 29562890 PMC5861650 · DOI
- [40]Yao X CRISPR/Cas9-mediated precise targeted integration in vivo using a double cut donor with short homology arms EBioMedicine 2017 20 19 26 10.1016/j.ebiom.2017.05.015 28527830 PMC5478232 · DOI
- [42]Xue W CRISPR-mediated direct mutation of cancer genes in the mouse liver Nature 2014 514 380 385 10.1038/nature13589 25119044 PMC4199937 · DOI · Paper page
- [45]Miura, K. Measurements of Intensity Dynamics at the Periphery of the Nucleus. (eds. Miura, K. & Sladoje, N) In: Bioimage Data Analysis Workflows. Learning Materials in Biosciences. (Springer, 2020).
- [47]Mane DR Kale AD Belaldavar C Validation of immunoexpression of tenascin-C in oral precancerous and cancerous tissues using ImageJ analysis with novel immunohistochemistry profiler plugin: an immunohistochemical quantitative analysis J. Oral Maxillofac. Pathol. 2017 21 211 217 10.4103/jomfp.JOMFP_234_16 28932029 PMC5596670 · DOI
- [48]Langmead B Salzberg SL Fast gapped-read alignment with Bowtie 2 Nat. Methods 2012 9 357 359 10.1038/nmeth.1923 22388286 PMC3322381 · DOI · Paper page
- [49]Li H The Sequence Alignment/Map format and SAMtools Bioinformatics 2009 25 2078 2079 10.1093/bioinformatics/btp352 19505943 PMC2723002 · DOI · Paper page
- [50]Ye K Schulz MH Long Q Apweiler R Ning Z Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads Bioinformatics 2009 25 2865 2871 10.1093/bioinformatics/btp394 19561018 PMC2781750 · DOI
Cited by
Sorted by citations
Chehelgerdi, M., Chehelgerdi, M., Khorramian-Ghahfarokhi, M., Shafieizadeh, M., Mahmoudi, E., Eskandari, F., Rashidi, M., Arshi, A., & Mokhtari-Farsani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01925-5 · Cited by 251 · see citing works
Dual-AAV delivering split prime editor system for in vivo genome editing
Zhi, S., Chen, Y., Wu, G., Wen, J., Wu, J., Liu, Q., Li, Y., Kang, R., Hu, S., Wang, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2021.07.011 · Cited by 174 · see citing works
Designing and executing prime editing experiments in mammalian cells
Doman, J. L., Sousa, A. A., Randolph, P. B., Chen, P. J., & Liu, D. R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00724-4 · Cited by 172 · see citing works
Genome-wide detection of CRISPR editing in vivo using GUIDE-tag
Liang, S.-Q., Liu, P., Smith, J. L., Mintzer, E., Maitland, S., Dong, X., Yang, Q., Lee, J., Haynes, C. M., Zhu, L. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28135-9 · Cited by 54 · see citing works
Self-citationRecent advances in prime editing technologies and their promises for therapeutic applications
Zeng, H., Daniel, T. C., Lingineni, A., Chee, K., Talloo, K., & Gao, X. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103071 · Cited by 27 · see citing works
Celotti, M., Derks, L. L. M., van Es, J., van Boxtel, R., Clevers, H., & Geurts, M. H. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103189 · Cited by 17 · see citing works
Prime-editing methods and pegRNA design programs
Mikhaylova, E. V., Kuluev, B. R., Gerashchenkov, G. A., Chemeris, D. A., Garafutdinov, R. R., Kuluev, A. R., Baymiev, A. K., Baymiev, A. K., & Chemeris, A. V. (2024) · Molecular Biology · doi:10.1134/s0026893324010084 · Cited by 15 · see citing works
Chromatin structure and context-dependent sequence features control prime editing efficiency
Kim, S., Yuan, J. B., Woods, W. S., Newton, D. A., Perez-Pinera, P., & Song, J. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1222112 · Cited by 12 · see citing works
Chanda, S., Lepikhov, K., Dahlem, C., Schymik, H. S., Hoppstädter, J., Geber, A.-K., Wagner, K., Kessler, S. M., Empting, M., & Kiemer, A. K. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901041 · Cited by 8 · see citing works
- Authors
- Liu, P., Liang, S.-Q., Zheng, C., Mintzer, E., Zhao, Y. G., Ponnienselvan, K., Mir, A., Sontheimer, E. J., Gao, G., Flotte, T. R., Wolfe, S. A., & Xue, W.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Wolfe, Scot A.
- Xue, Wen
- ORCID
- Venue
- Nature Communications
- Published
- 2021-04-09
- Volume
- 12
- Issue
- 1
- Pages
- 2121-2121
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8035190
- OpenAlex
- W3145074783
- Cited by
- 273
- References
- 9
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 56 · 2023: 67 · 2022: 59 · 2021: 21
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cystic Fibrosis Foundation (UG3TR002668, R01GM115911)
- Lung Cancer Research Foundation
- Rett Syndrome Research Trust
- National Institutes of Health (UG3TR002668, UH3TR002668)
- National Heart, Lung, and Blood Institute (P01HL131471, DP2HL137167, UG3HL147367)
- National Institute of General Medical Sciences (R01GM115911)
- National Institute of Neurological Disorders and Stroke (R01NS111990)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- prime editing, SpCas9, pegRNA, nuclear localization signal, adeno-associated virus vectors, tumor formation, cancer modelling, liver, adult mice, in vivo gene editing
- MeSH terms
- Gene Editing, Dependovirus, Alleles, Animals, Disease Models, Animal, HeLa Cells, Humans, Neoplasms, Transfection, Mice, HEK293 Cells, Carcinogenesis, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review